Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens
Devivasha Bordoloi(The Wistar Institute), Kar Muthumani(The Wistar Institute)
Cited by 14
Related Papers
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
|npj Vaccines|2016|136
An Investigation on the Therapeutic Potential of Butein, A Tretrahydroxychalcone Against Human Oral Squamous Cell Carcinoma
|Asian Pacific Journal of Cancer Prevention|2019|53
TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-κB Signaling Cascade
|Biomolecules|2019|51
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
|Cancer Immunology Immunotherapy|2017|42